Eiko Lifesciences Delivers 16% Revenue Growth, Enters Container Leasing & Logistics Sector

Eiko Lifesciences Ltd. reported solid financial results for FY 2024-25, with a 16% increase in revenue from operations to 3,249.18 lakhs. Profit after tax nearly doubled to 174.08 lakhs, and EBITDA margin improved from 6.4% to 9.46%. The company also expanded into the container leasing and logistics sector through a dedicated subsidiary, and launched Eiko Scientific Solutions LLP for research and development in specialty chemicals and healthcare innovation. These strategic moves aim to build a more integrated and resilient value chain and position the company for long-term growth.